North America Computed Tomography (CT) Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

North America Computed Tomography (CT) Market Trends and Insights

Rising Prevalence of Chronic Diseases

With rising cancer rates and increasing cardiac risk factors, the demand for imaging services remains a critical component of healthcare budgets. Projections indicate a 3.2% increase in new cancer cases in the United States, reaching 2.1 million cases by 2026.^{[3]American College of Cardiology, “2024 Chest Pain Guideline,” acc.org}Additionally, nearly half of United States adults are managing at least one chronic condition, driving the need for regular CT surveillance. Expanded eligibility for lung cancer screenings in 2021 is expected to add 6.4 million new candidates by 2025, although current uptake remains below 20%, presenting significant growth potential. Updated 2024 guidelines have positioned coronary CT angiography as the preferred method for evaluating stable chest pain, shifting referrals away from traditional catheterization. By 2030, adults aged 65 and older will account for 21% of the United States population.^{[4]U.S. Census Bureau, “2025 Population Estimates,” census.gov} This age group, which utilizes CT scans at a rate 3.5 times higher than younger individuals, is expected to drive sustained growth in imaging volumes.

Advances in Low-Dose Multi-Slice CT Technology

Photon-counting detectors and deep-learning reconstruction cut dose while heightening contrast resolution, expanding CT’s utility in pediatric and screening workflows. Siemens’ NAEOTOM Alpha received Health Canada clearance in 2024, opening the door for competing photon-counting systems. Canon’s DLIR platform trimmed reconstruction steps by 40%, evidencing measurable workflow savings. FDA data show that 80% of AI devices cleared in 2024 targeted imaging, underscoring a regulatory environment that rewards dose-efficient innovation.

Expanding Geriatric Imaging Volumes

North America’s 65-plus population demonstrates CT utilization rates three to four times higher than those of younger cohorts, driven by complex diagnostic requirements. Outpatient visits among Medicare recipients grew 14% from 2005 to 2015 and continue to rise. Provincial authorities in Canada responded by allocating CAD 10 million (USD 7.4 million) to new scanners in British Columbia alone. These demographic realities lock in long-run baseline growth for the North America computed tomography market.

Favorable Reimbursement & Replacement Cycles

Medicare’s doubling of coronary CT angiography rates to USD 357.13 applies an immediate margin uplift for cardiac imaging providers. Concurrently, non-compliant equipment now incurs 15% reimbursement penalties under the NEMA XR-29 smart-dose rule, compressing replacement timelines. Combined, these policies accelerate capital refresh across U.S. hospitals, lifting order volumes throughout the forecast horizon.

High Capital & Service Costs

Premium photon-counting CT platforms can cost up to USD 5 million, a hurdle for low-volume centers. Annual service contracts range from 8% to 12% of the the purchase price, compounding budgetary strain. Leasing alleviates upfront outlays but often results in higher total lifecycle spend, reinforcing economic disparities between urban academic hospitals and rural providers.

Radiation-Dose Safety Concerns

Regulators and advocacy groups maintain strict oversight on radiation exposure, particularly for children. The FDA’s Mammography Quality Standards Act framework extends to CT dose monitoring, mandating rigorous compliance protocols. Campaigns such as Image Gently influence clinician ordering behavior, tempering utilization in dose-sensitive applications until next-generation detectors become mainstream.

Segment Analysis

By Technology: Photon-Counting Drives Premium Tier

High-slice systems (≥128-slice) are projected to grow at a rate of 6.94% from 2026 to 2031, surpassing the overall North American computed tomography (CT) market. This growth is driven by cardiology and oncology teams seeking spectral data and sub-millimeter resolution, capabilities that medium-slice scanners cannot provide. In 2025, medium-slice platforms captured 44.16% of the North American CT market share, as community hospitals and outpatient imaging centers prioritized cost and routine abdomen-pelvis throughput. Low-slice models have found their niche in orthopedic extremity and veterinary applications, where their compact size and pricing under USD 500,000 compensate for their limited coverage.

Photon-counting adoption marks a pivotal shift. In 2025, Siemens dispatched 120 NAEOTOM Alpha units throughout North America. Notably, early adopters bypassed 256-slice upgrades, highlighting benefits like 60% savings on iodine contrast and the removal of beam-hardening artifacts. Vendors lacking photon-counting capabilities face potential exclusion from lucrative high-margin cardiac contracts, especially where ALARA dose metrics are paramount.

Note: Segment shares of all individual segments available upon report purchase

By Product Type: Portability Gains in Point-of-Care Settings

In 2025, stationary scanners constituted 85.79% of the North American CT market, capitalizing on a throughput of 20–30 patients per day and established reimbursement pathways. Meanwhile, portable and mobile units are on a growth trajectory, with a projected CAGR of 7.09% through 2031. This surge is driven by the formalization of bedside CT protocols in emergency rooms, ICUs, and rural clinics. For instance, Samsung NeuroLogica’s CereTom, weighing in at 385 pounds, is favored by neuro-critical-care units for its ability to perform non-contrast head CTs without relocating ventilated patients.

Contract radiology firms operate mobile fleets catering to rural hospitals without on-site CT capabilities. Additionally, FEMA has stockpiled portable systems for disaster response scenarios. The continued reimbursement parity under Medicaid waivers bolsters capital investments in states with widely dispersed populations.

By Application: Cardiovascular Imaging Accelerates on Guideline Tailwinds

In 2025, oncology procedures made up 31.18% of the volume, driven by mandates for lung-cancer screenings and the need for monitoring immunotherapy. Cardiovascular CT is poised for a 6.71% growth from 2026 to 2031, spurred by ACC guidelines elevating coronary CT to Class I status for stable chest pain, thus steering patients away from invasive angiography. Neurology stands as the second-largest application, bolstered by stroke protocols that necessitate head CTs within 20 minutes of a patient's arrival at the emergency department. Cone-beam CT is making inroads into musculoskeletal practices, offering extremity imaging at just one-tenth the dose of conventional methods. While demand for pulmonary CT has stabilized post-COVID, it continues to be supported by follow-ups for COPD.

As photon-counting detectors enhance plaque visualization and lessen contrast load, the North American CT market anticipates steady growth in cardiovascular applications. This advancement promises heightened diagnostic accuracy for at-risk yet asymptomatic populations.

Note: Segment shares of all individual segments available upon report purchase

By End User: Ambulatory Centers Capture Outpatient Shift

In 2025, hospitals accounted for 55.15% of the installed CT capacity, driven by trauma and tertiary-care needs that necessitate high-slice platforms. However, ambulatory surgical centers are witnessing a robust growth rate of 7.34% from 2026 to 2031. This surge is largely attributed to payer site-of-service edits, which direct elective scans to these more cost-effective venues. Diagnostic imaging centers, already handling a quarter of regional procedures, capitalize on extended operational hours and offer reimbursement rates that are 40–50% lower than those of hospital outpatient departments.

Orthopedic surgery centers are leveraging same-day CTs for pre-operative planning, leading to shorter hospital stays and heightened patient satisfaction. Even in their niche, veterinary clinics are rapidly adopting scanners, driven by a surge in pet-insurance uptake that facilitates advanced diagnostics.

Geography Analysis

Computed Tomography Market in North America

In 2025, the United States accounted for a dominant 92.67% of the region's CT revenue. Projections indicate a robust growth rate of 7.85% through 2031, driven by Medicare Advantage's enrollment surge to 33 million beneficiaries in 2025 and the expanded eligibility for lung-cancer screenings. States such as California, Texas, and Florida, with large senior populations and extensive outpatient imaging networks, contributed a notable 38% to United States installations.

Canada holds a modest 5% share of North America's CT market, with growth constrained by provincial budget cycles. However, pilot programs in Ontario and Quebec aim to centralize e-referrals, potentially reducing wait times from eight weeks to under two, thereby unlocking significant pent-up demand. Meanwhile, Mexico, with a share of less than 3%, is experiencing the fastest growth. Private hospital chains, such as Grupo Angeles, are investing in 64- and 128-slice systems to cater to medical tourists and a growing middle class. The federal health-infrastructure plan for 2025-2030 has allocated USD 1.2 billion for diagnostic equipment, creating tenders that appeal to mid-tier vendors willing to structure peso-denominated financing.